Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NYSE | Common Stock
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States.
Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 24 | -1.08 Decreased by -575.00% | -3.32 Increased by +67.49% |
| Aug 9, 24 | -4.40 Decreased by -4.79 K% | -3.12 Decreased by -41.03% |
| May 9, 24 | -0.08 Increased by +27.27% | -0.08 |
| Feb 29, 24 | -0.11 Decreased by -22.22% | -0.10 Decreased by -10.00% |
| Nov 8, 23 | -0.16 Increased by +60.98% | -0.09 Decreased by -77.78% |
| Aug 9, 23 | -0.09 Increased by +79.07% | -0.08 Decreased by -12.50% |
| May 10, 23 | -0.11 Increased by +63.33% | -0.09 Decreased by -22.22% |
| Mar 1, 23 | -0.09 Increased by +90.91% | -0.21 Increased by +57.14% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 89.05 M Increased by +60.65% | -56.40 M Increased by +81.38% | Decreased by -63.34% Increased by +88.41% |
| Jun 30, 24 | 56.21 M Decreased by -30.24% | -217.18 M Decreased by -25.31% | Decreased by -386.40% Decreased by -79.62% |
| Mar 31, 24 | 37.94 M Decreased by -52.98% | -165.91 M Increased by +19.06% | Decreased by -437.25% Decreased by -72.16% |
| Dec 31, 23 | 34.76 M Decreased by -64.64% | -211.69 M Decreased by -19.91% | Decreased by -609.10% Decreased by -239.10% |
| Sep 30, 23 | 55.43 M Decreased by -16.52% | -302.89 M Increased by +54.80% | Decreased by -546.44% Increased by +45.86% |
| Jun 30, 23 | 80.57 M Decreased by -44.29% | -173.31 M Increased by +74.09% | Decreased by -215.12% Increased by +53.49% |
| Mar 31, 23 | 80.70 M Decreased by -52.08% | -204.97 M Increased by +65.29% | Decreased by -253.98% Increased by +27.57% |
| Dec 31, 22 | 98.28 M Decreased by -33.81% | -176.54 M Increased by +88.97% | Decreased by -179.62% Increased by +83.34% |